What is the primary purpose of these new 'change in control' agreements?

The primary purpose is to ensure executive retention and provide financial security to key members of the Corporate Executive Committee in the event of a change in control of the company. These agreements aim to align executive interests with shareholder interests during potentially disruptive periods and to incentivize executives to remain with the company.

What constitutes a 'Change in Control' according to these agreements?

A 'Change in Control' is defined by several criteria: acquisition of 30% or more of the company's voting power by a single party or group; a majority turnover in the Board of Directors within two years without prior board approval; or any other event determined by the Board to constitute a change in control.

What are the key severance components for an executive if a change in control occurs and their employment is terminated?

If an executive's employment is terminated without 'Cause' or by the executive for 'Good Reason' within two years of a 'Change in Control,' they are entitled to a pro-rata target annual incentive award, a cash payment equal to two or three times their base salary and target annual incentive, and a cash payment related to defined contribution plans. They also receive enhanced pension benefits or contributions, continuation of health and insurance benefits, and outplacement services.

How are outstanding stock options and other equity awards treated upon a 'Change in Control'?

Upon a 'Change in Control,' outstanding stock options and stock appreciation rights held for at least six months become immediately exercisable. Restricted stock restrictions lapse, and deferred stock units vest. At the discretion of the compensation committee, these equity awards may be exchanged for a cash payment based on the 'Change in Control Price.'

APD 8-K: Leadership Changes

Summary

This 8-K filing from Air Products & Chemicals, Inc. (APD) on December 20, 2007, details the implementation of new change in control severance agreements for all members of the Company's Corporate Executive Committee. These agreements are designed to provide financial and other benefits to key executives in the event of specific circumstances related to a change in company control, such as termination of employment without cause or by the executive for good reason, within two years of such a control event. The filing outlines the definitions of 'Cause,' 'Good Reason,' and 'Change in Control,' providing clarity on the triggers for these agreements. For investors, the primary takeaway is the company's proactive approach to executive retention and alignment during potential periods of uncertainty or transition. The severance packages are structured to include a combination of cash payments (base salary, incentive awards, retirement plan contributions), continuation of benefits, and outplacement services. Notably, specific executives, including the CEO, CFO, and SVP of Human Resources, receive enhanced benefits (three times salary and incentive, three years of benefit continuation) compared to other covered executives (two times salary and incentive, two years of benefit continuation). The agreements also address the treatment of outstanding equity awards upon a change in control, ensuring they become exercisable or are converted into cash, offering further protection and potential upside for executives.

Key Highlights

1Air Products & Chemicals, Inc. has entered into new change in control severance agreements for its Corporate Executive Committee.
2These agreements are triggered by specific events within two years of a 'Change in Control,' including termination without cause or resignation for 'Good Reason.'
3Severance benefits include pro-rata annual incentives, cash payments equivalent to two or three times base salary and target incentive, and other compensation-related benefits.
4Key executives (CEO, CFO, SVP-HR) receive enhanced severance packages (three times salary/incentive, three years of benefit continuation).
5Benefits also cover continuation of medical, dental, disability, and life insurance for two or three years.
6Outstanding equity awards (stock options, SARs, restricted stock, deferred stock units) will be addressed, with provisions for immediate exercisability or cash conversion.
7The agreements include provisions for tax gross-ups on excess parachute payments under specific conditions.

Air Products & Chemicals, Inc. 8-K Report, Executive Changes (Dec 20, 2007)

Summary

Key Highlights

Frequently Asked Questions